Company intelligence / Profile preview
VIVEX Biologics
Opa-locka / Miami area, Florida, United Statesvivex.com ↗
- Ownership
- Private
- Employees
- ~238
- Development stage
- Other
01
Overview
VIVEX Biologics has distributed over two million allografts nationwide with no reported cases of disease transmission. Their products are used in more than 100,000 patients annually for a variety of orthopedic and wound care indications. Clinical studies have been completed on their VIA Graft product line with published results.
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- AllograftCell therapyAmniotic tissue-based therapyHuman tissue-derived biologic
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Legacy Donor Services Foundation (tissue recovery partner)Distribution partners for amnion & wound care network expansion
Beyond the preview
Go deeper on VIVEX Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VIVEX Biologics.